These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29043811)

  • 1. Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method.
    Plum J; Madsen CM; Teleki A; Bevernage J; da Costa Mathews C; Karlsson EM; Carlert S; Holm R; Müller T; Matthews W; Sayers A; Ojala K; Tsinsman K; Lingamaneni R; Bergström CA; Rades T; Müllertz A
    Mol Pharm; 2017 Dec; 14(12):4161-4169. PubMed ID: 29043811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach.
    Palmelund H; Madsen CM; Plum J; Müllertz A; Rades T
    J Pharm Sci; 2016 Oct; 105(10):3021-3029. PubMed ID: 27488902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations.
    Price DJ; Nair A; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2019 Apr; 132():142-156. PubMed ID: 30877067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
    Berben P; Ashworth L; Beato S; Bevernage J; Bruel JL; Butler J; Dressman J; Schäfer K; Hutchins P; Klumpp L; Mann J; Nicolai J; Ojala K; Patel S; Powell S; Rosenblatt K; Tomaszewska I; Williams J; Augustijns P
    Eur J Pharm Biopharm; 2019 Jul; 140():141-148. PubMed ID: 31051249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating side-by-side diffusion models for studying drug supersaturation in an absorptive environment: a case example of fenofibrate and felodipine.
    Eliasen JN; Berthelsen R; Slot AL; Müllertz A
    J Pharm Pharmacol; 2020 Mar; 72(3):371-384. PubMed ID: 31876955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
    Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations.
    Alskär LC; Keemink J; Johannesson J; Porter CJH; Bergström CAS
    Mol Pharm; 2018 Oct; 15(10):4733-4744. PubMed ID: 30142268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.
    Tanaka Y; Tay E; Nguyen TH; Porter CJH
    Pharm Res; 2020 Feb; 37(3):47. PubMed ID: 32016597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.
    Suys EJA; Brundel DHS; Chalmers DK; Pouton CW; Porter CJH
    J Control Release; 2021 Mar; 331():45-61. PubMed ID: 33450318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of nonionic surfactant used to formulate type IIIA self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion.
    Devraj R; Williams HD; Warren DB; Porter CJ; Pouton CW
    J Pharm Sci; 2014 Apr; 103(4):1050-63. PubMed ID: 24470073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior.
    Cavanagh KL; Kuminek G; Rodríguez-Hornedo N
    Mol Pharm; 2020 Nov; 17(11):4286-4301. PubMed ID: 32815731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Video-Microscopic Tool To Evaluate the Precipitation Kinetics of Poorly Water Soluble Drugs: A Case Study with Tadalafil and HPMC.
    Christfort JF; Plum J; Madsen CM; Nielsen LH; Sandau M; Andersen K; Müllertz A; Rades T
    Mol Pharm; 2017 Dec; 14(12):4154-4160. PubMed ID: 28763224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption Periods.
    Crum MF; Trevaskis NL; Pouton CW; Porter CJ
    Mol Pharm; 2017 Feb; 14(2):394-405. PubMed ID: 28002666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.
    Quan G; Niu B; Singh V; Zhou Y; Wu CY; Pan X; Wu C
    Int J Nanomedicine; 2017; 12():8801-8811. PubMed ID: 29263669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of supersaturation and in vitro permeation of the poorly water soluble drug ezetimibe.
    Alhayali A; Selo MA; Ehrhardt C; Velaga S
    Eur J Pharm Sci; 2018 May; 117():147-153. PubMed ID: 29408604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
    Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
    Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.